Skip to main content
. 2024 May 23;15:4350. doi: 10.1038/s41467-024-48555-z

Fig. 7. H5 HA mRNA-LNP vaccine protects ferrets from clade 2.3.4.4b H5 virus infection.

Fig. 7

Four ferrets per group were immunized with 60 μg A/Astrakhan/3212/2020 HA mRNA-LNP (H5 mRNA-LNP) or Luciferase mRNA-LNP (control), followed by a 60 μg boost 28 days later. Ferrets were challenged i.n. with A/bald eagle/Florida/ W22-134-OP/2022 28 days after the second vaccination and then monitored for 14 days after infection. A Survival, (B) body weight, (C) 50% tissue culture infectious dose (TCID50) virus titers in nasal wash samples and (D) clinical scores are reported after infection. Data in (A) were analyzed using a log rank test. Data in (B, C) are shown as means ± SEMs. Data in (B, C) were analyzed by multiple unpaired two-sided t tests with Gaussian distribution to compare differences with luciferase (control) mRNA immunization. A *P = 0.0009; (B) Day 2 *P = 0.005166, day 3 *P = 0.000095, day 4 *P = 0.000087, day 5 *P = 0.003561 and day 6 *P = 0.001509; (C) *P = 0.000269. Source data are provided as a Source Data file.